Chularat Hospital Public Company (CHG) Fair Value & Analysis
Healthcare · TH · Market cap 15.5B THB
Fair value as of: Jun 24, 2026
From 26 valuation models · updated 5 days ago
Share price +11.1% over the past month.
Price vs Fair Value (12 months)
12‑month range 1.24 THB – 1.66 THB · fair‑value band 1.38 THB – 2.32 THB · the 1.51 THB price screens below the 1.86 THB fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Chularat Hospital Public Company (CHG) currently trades at 1.51 THB, while our model-based Fair Value estimate is 1.86 THB — implying the stock looks roughly 23.2% undervalued today. We read business quality at 89/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Over the trailing twelve months, Chularat Hospital Public Company generated revenue of 8.5B THB at a net margin of 11.2%. Revenue grew 4.5% year over year. It earns a return on equity of 11.7%. The balance sheet holds a net cash position of 1.2B THB. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Chularat Hospital Public Company Limited, together with its subsidiaries, operates clinics and hospitals in Thailand. The company also provides a comprehensive health screening center. In addition, it sells medicine and medical supplies. Chularat Hospital Public Company Limited was founded in 1986 and is headquartered in Samut Prakan, Thailand.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Chularat Hospital Public Company reported revenue of 8.3B THB in FY2025 versus 11.7B THB in FY2021, a compound −8.2%/yr. Reported net income was 929M THB in FY2025, compounding −31.4%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$97.60 | R$115.75 | +19% |
| Fresenius SE FSNUY | $11.47 | $8.55 | -25% |
| 5225 5225 | 8.70 MYR | 2.61 MYR | -70% |
| IHHHF IHHHF | $1.71 | $1.26 | -26% |
| Tenet Healthcare Corporation THC | $178.75 | $300.86 | +68% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.83 | R$46.94 | +39% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Chularat Hospital Public Company (CHG) undervalued?
What is the fair value of CHG?
What is the quality score of CHG?
What is the revenue of Chularat Hospital Public Company (CHG)?
What is the net profit margin of CHG?
Does Chularat Hospital Public Company pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.